Literature DB >> 15184248

Variation in estradiol, estradiol precursors, and estrogen-related products in nipple aspirate fluid from normal premenopausal women.

Robert T Chatterton1, Angela S Geiger, Seema A Khan, Irene B Helenowski, Borko D Jovanovic, Peter H Gann.   

Abstract

The purpose of the study was to measure the concentrations of estradiol, its primary precursors, and factors with which it interacts in the breast, and determine their sources of variation. Nipple aspirate fluid (NAF) was collected from premenopausal women during the mid-luteal phase of the menstrual cycle. The fluid was diluted and unconjugated steroids were extracted. Estradiol was further purified by a solvent partition into aqueous NaOH. Androgens were measured in the non-phenolic fraction. Water-soluble, conjugated steroids and proteins were measured in the aqueous residue. All analytes were measured by immunoassays. Permutation methods were used to determine the correlations over multiple periods of time. The average concentration of estradiol in NAF was 435 pmol/L after purification but was many times higher when assayed without purification. Estrone and dehydroepiandrosterone (DHEA) sulfates were present in 3.7 and 75 micromol/L concentrations, respectively, while unconjugated androstenedione and DHEA were present in nanomole per liter concentrations. Lack of the steroid sulfates in NAF in 19% of subjects had no effect on NAF estradiol levels but was associated with a 77% lower concentration of unconjugated DHEA. Progesterone was present in concentrations that were 3- to 4-fold higher than normal serum concentrations (mean: 291 nmol/L). Cathepsin D, epidermal growth factor, and interleukin 6 had average values of 3.4 microg/mL, 424 ng/mL, and 1.7 ng/mL, respectively. Correlations between breasts were between 0.57 and 0.84 for the several analytes; correlations over time ranged from 0.64 and 0.93 with estrone sulfate highest in both categories. The lower correlation between breasts than within breasts indicates that local factors play an important role in determining the levels of many of these analytes in the breast. The high stability of the concentrations of several analytes over time indicates that fluctuations in environmental factors have little immediate effect on levels in the breast, and portends their utility as surrogate breast cancer risk markers.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15184248

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  15 in total

1.  Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial.

Authors:  Seema A Khan; Robert T Chatterton; Nancy Michel; Michelle Bryk; Oukseub Lee; David Ivancic; Richard Heinz; Carola M Zalles; Irene B Helenowski; Borko D Jovanovic; Adrian A Franke; Maarten C Bosland; Jun Wang; Nora M Hansen; Kevin P Bethke; Alexander Dew; Margerie Coomes; Raymond C Bergan
Journal:  Cancer Prev Res (Phila)       Date:  2012-02

Review 2.  Estrogens in the breast tissue: a systematic review.

Authors:  Lusine Yaghjyan; Graham A Colditz
Journal:  Cancer Causes Control       Date:  2011-02-01       Impact factor: 2.506

3.  Nipple Aspirate Fluid Hormone Concentrations and Breast Cancer Risk.

Authors:  Robert T Chatterton; Richard E Heinz; Angela J Fought; David Ivancic; Claire Shappell; Subhashini Allu; Susan Gapstur; Denise M Scholtens; Peter H Gann; Seema A Khan
Journal:  Horm Cancer       Date:  2016-02-22       Impact factor: 3.869

4.  Estrogen levels in nipple aspirate fluid and serum during a randomized soy trial.

Authors:  Gertraud Maskarinec; Nicholas J Ollberding; Shannon M Conroy; Yukiko Morimoto; Ian S Pagano; Adrian A Franke; Elisabet Gentzschein; Frank Z Stanczyk
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-07-08       Impact factor: 4.254

5.  Breast ductal lavage for assessment of breast cancer biomarkers.

Authors:  Robert Treat Chatterton; Noah P Parker; Mito Habe-Evans; Michele Bryk; Denise M Scholtens; Seema A Khan
Journal:  Horm Cancer       Date:  2010-08       Impact factor: 3.869

Review 6.  Nipple aspirate fluid and its use for the early detection of breast cancer.

Authors:  Natasha Jiwa; Ahmed Ezzat; Josephine Holt; Dhuleep S Wijayatilake; Zoltan Takats; Daniel Richard Leff
Journal:  Ann Med Surg (Lond)       Date:  2022-04-18

7.  Hormonal determinants of nipple aspirate fluid yield among breast cancer cases and screening controls.

Authors:  Angela J Fought; Claire McGathey; Denise M Scholtens; Richard E Heinz; Rick Lowe; Yvonne B Feeney; Oukseub Lee; Thomas E Kmiecik; Judith A Wolfman; Charles V Clevenger; Peter H Gann; Susan Gapstur; Robert T Chatterton; Seema A Khan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-09-18       Impact factor: 4.254

8.  Status of Intraductal Therapy for Ductal Carcinoma in Situ.

Authors:  Meghan Flanagan; Susan Love; E Shelley Hwang
Journal:  Curr Breast Cancer Rep       Date:  2010-05-06

9.  Protein Biomarkers for Breast Cancer Risk Are Specifically Correlated with Local Steroid Hormones in Nipple Aspirate Fluid.

Authors:  Ali Shidfar; Tolulope Fatokun; David Ivancic; Robert T Chatterton; Seema A Khan; Jun Wang
Journal:  Horm Cancer       Date:  2016-04-19       Impact factor: 3.869

10.  The Fourth International Symposium on the Intraductal Approach to Breast Cancer, Santa Barbara, California, 10-13 March 2005.

Authors:  Bonnie L King; Susan M Love; Susan Rochman; Julian A Kim
Journal:  Breast Cancer Res       Date:  2005-07-20       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.